- Harmonizing Data Collection for Precision Oncology: AACR Project GENIE® Data Model
- Unboxing Cancer News, August 2026: Fishy Cancer, Federal- vs. Industry-funded Trials, and More
- Breaking News: Daraxonrasib Approved for Pancreatic Cancer
- Driving CAR T-cell Therapy in New Directions
- Editors’ Picks, August 2026: Weight Loss and Breast Cancer Biomarkers, Predicting Early-onset Cancer Cases, and More
- How New Science is Reshaping Ovarian Cancer Treatment and Care
- Smart Chemotherapy Gets Smarter: Advances in Antibody-drug Conjugates
- AACR in the News: Cancer Disparities Progress Report and OMB Statement
- What Are Antibody-drug Conjugates?
- AACR D3 Offered a Peek Into the Cancer Drug Pipeline, Innovative AI Tools, and More
- From the Bench, AACR D3 2026: Emerging Therapeutic Strategies to Inhibit KRAS, Enhance ADCs, and Tackle Resistance
- What Is CAR T-cell Therapy?
- Editors’ Picks, July 2026: AI-powered Pancreatic Proteomics, Sex-based Immune Differences, and More
- Cancer Today’s Summer 2026 Issue: Using Patient-reported Outcomes to Address Side Effects, Preventing Graft-versus-host Disease, and More
- Inaugural AACR D3 Opens With Insights From Leaders Across Drug Discovery and Development
